• Beyond Staining: Golgi Imaging for Translation

  2026-09-13

  Golgi-Tracker Green provides a photostable live-cell view of Golgi organization, lipid transport, and sphingolipid biology. This thought-leadership perspective connects BODIPY FL-labeled C5-ceramide imaging with emerging oncology evidence on Golgi fragmentation, while defining the assay controls and translational limits researchers should address.

• Golgi-Tracker Green: Live-Cell Workflow Guide

  2026-09-12

  Golgi-Tracker Green enables selective, photostable visualization of Golgi membranes in living cells, supporting organelle dynamics, lipid transport, and sphingolipid studies. This guide translates the probe into practical labeling workflows and shows how Golgi morphology can complement cancer-stress assays without confusing imaging evidence with mechanistic proof.

• Thapsigargin Workflows for SERCA and ER Stress

  2026-09-11

  Thapsigargin provides a fast, tunable way to connect SERCA inhibition with calcium imaging, endoplasmic reticulum stress, and apoptosis readouts. This practical guide translates a pulmonary inflammation study into assay-ready workflows while showing how to control dose, timing, cell context, and interpretation.

• Berberine Hydrochloride: AMPK Assay Design

  2026-09-11

  Berberine hydrochloride is more than an AMPK-associated metabolic probe. This guide connects its lipid, apoptosis, and ferroptosis biology with a cross-validated cardiomyocyte assay strategy inspired by recent AMPK–mitochondrial research.

• Pioglitazone: From PPARγ to Translational Insight

  2026-09-10

  Pioglitazone is more than a metabolic research reagent: it is a mechanistic probe for linking PPARγ activation with macrophage state, barrier integrity, beta cell resilience, and neuroinflammatory responses. This perspective translates recent DSS-induced inflammatory bowel disease findings into a practical framework for designing reproducible, cross-domain studies.

• ZIF-8–PEI Platforms for mRNA Delivery

  2026-09-10

  The ChemRxiv study develops a ZIF-8 metal-organic framework system for mRNA encapsulation and identifies polyethyleneimine (PEI) incorporation as a solution to rapid cargo leakage. The resulting platform retained mRNA longer in biological media, supported protein expression across multiple cell lines, and enabled expression after room-temperature storage for three months, although the findings remain pre-peer-review.

• Drug Response Metrics in Cancer: Beyond Viability

  2026-09-09

  Hannah R. Schwartz’s dissertation distinguishes relative viability from fractional viability to separate growth arrest from drug-induced cell death in cancer models. This framework improves interpretation of treatment response by emphasizing response proportions, timing, and orthogonal validation rather than relying on a single viability endpoint.

• Reelin Signaling Permits Ketamine’s Synaptic Effects

  2026-09-09

  This PNAS study identifies Reelin–Apoer2–Src family kinase signaling as a permissive pathway for ketamine-induced hippocampal synaptic plasticity and behavioral effects. Its findings suggest that impaired baseline NMDA receptor function, rather than a simple failure of ketamine target engagement, may contribute to nonresponse to ketamine treatment.

• PPT: Selective ERα Agonist for Reliable Assays

  2026-09-08

  This scenario-based guide explains how PPT (Propyl Pyrazole Triol), a potent, selective ERα agonist, can improve interpretation of viability, proliferation, and cytotoxicity assays. It covers SKU B6735 handling, controls, ERα-specific readouts, and vendor-selection criteria for reproducible laboratory workflows.

• EZ Cap™ Cy5 EGFP mRNA: Delivery Workflows

  2026-09-08

  EZ Cap™ Cy5 EGFP mRNA (5-moUTP) separates mRNA uptake from functional translation through Cy5 and EGFP signals in the same experiment. This practical guide shows how to screen delivery systems, interpret discordant readouts, and connect cellular results with RNA–nanoparticle structure.

• PPT for ERα Signaling in LUAD

  2026-09-07

  PPT (Propyl Pyrazole Triol) provides a selective way to perturb ERα signaling while minimizing ERβ-driven interpretation. This guide translates that pharmacology into practical workflows for biomarker validation, female lung adenocarcinoma research, uterotrophic assays, and troubleshooting.

• Foretinib (GSK1363089) Assay Workflows

  2026-09-07

  Foretinib (GSK1363089) supports integrated studies of tumor cell growth inhibition, motility, invasion, and metastatic behavior through coordinated Met and VEGFR pathway blockade. This practical guide combines formulation guidance with response metrics that distinguish proliferative arrest from true cell death.

• ISRIB (trans-isomer) Workflow for ISR Research

  2026-09-05

  Build sharper ER stress and memory-retention experiments with ISRIB (trans-isomer), a potent PERK inhibitor and functional eIF2B activator. The workflow connects biochemical target engagement to translation, apoptosis, and recognition-memory readouts while separating literature-supported findings from practical optimization choices.

• LY294002 Workflows for PI3K/Akt Cancer Assays

  2026-09-04

  Build cleaner PI3K/Akt experiments with LY294002 by combining dose-response design, timed pathway readouts, and viability controls. The workflow translates recent SPP1–macrophage findings in oesophageal squamous cell carcinoma into practical co-culture, apoptosis, autophagy, and tumor-biology assays.

• Estradiol, ER Signaling, and T-Cell Recovery After Shock

  2026-09-04

  This study identifies endoplasmic reticulum stress as a mechanistic link between hemorrhagic shock and impaired splenic CD4+ T-lymphocyte function. Its pharmacological experiments indicate that estradiol acts principally through ERα and GPR30 to suppress stress signaling, preserve T-cell proliferation and cytokine production, and reduce splenic injury.

541 records 1/37 page Next 12345 下5页 Last page